News
3 Turnaround Stocks in the Early Innings With More Upside to Come
“Turnaround” is a magic word for investors looking to get into a stock at cheap valuations. It’s a key justification for entering stocks that have been left for dead. It's also a term that gets
Trump Index: 6 Companies Linked to Trump’s Cabinet Worth Watching
President Donald Trump's cabinet is often referred to as "The Avengers," with each member being accomplished in their field of expertise. Trump’s cabinet has an overwhelming number of successful
Top 5 AI Stocks to Boost Your Portfolio in 2025
Tide Shifts for 3M: How to Profit from the Rally
3M (NYSE: MMM) faced many struggles but has overcome them and embarked on a new age of growth. Hurdles, including multiple legal issues, are in the rearview mirror, and the road ahead is
3 Small-Cap Stocks Insiders and Institutions Are Buying
Insider activity is seldom enough to move a market independently but can signal how a company’s management thinks. Those signals become strong when the institutional and analysts' activity aligns
Avient Stock: Manufacturing Play With Double-Digit Upside
Coming up with a great trade idea is easier than most investors think. They just need to get their hands on the right tools and datasets to arrive at said ideas. After that, it all comes down to
After a Reset Year, Is Moderna Stock Poised for a Comeback?
Biotechnology company Moderna Inc. (NASDAQ: MRNA) gained the spotlight in the medical sector as a leader in the race toward a COVID-19 vaccine. Its messenger RNA (mRNA) technology garnered
3 Stocks to Gain From Donald Trump’s External Revenue Service
President Trump announced his plan for a federal agency called the “External Revenue Service” to handle the collection of tariffs and fees from other nations. Trump had previously stated he would
Santhera erhält positive endgültige NICE-Empfehlung für AGAMREE® (Vamorolon) zur Behandlung von Duchenne-Muskeldystrophie
- Santhera hat mit den Vorbereitungen für die Markteinführung von AGAMREE® im Vereinigten Königreich begonnen und erwartet die ersten Verkäufe in diesem Quartal
Pratteln, Schweiz, 16. Januar 2025 –
Santhera erhält positive Empfehlung vom Scottish Medicines Consortium für den Einsatz von AGAMREE® (Vamorolon) bei Patienten mit Duchenne-Muskeldystrophie in Schottland
Santhera erhält positive Empfehlung vom Scottish Medicines Consortium für den Einsatz von AGAMREE® (Vamorolon) bei Patienten mit Duchenne-Muskeldystrophie in Schottland
- AGAMREE® ist von der MHRA
KI-gestützte Mammographie verbessert die Brustkrebserkennung: Weltweit größte Studie aus Deutschland bestätigt erstmalig erfolgreichen Einsatz in der Praxis
BERLIN, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Wie in BBC und The Guardian berichtet, liefert heute eine Studie den ersten Praxisbeweis für das Potenzial der künstlichen Intelligenz, die
Top 3 Preferred Stock ETFs Offering Stability and High Dividends
2025 marks a time of uncertainty for many investors—despite stellar performance in 2024 and a post-election bump that lasted through mid-December, the S&P 500 and the market as a whole face
AppLovin’s AI Potential: Can the Momentum Continue?
AppLovin Corp. (NASDAQ: APP)stock jumped 166% after a strong earnings report in November. That made APP stock the top performer among stocks in the NASDAQ 100 in 2024. But after that spectacular
3 Compelling Reasons to Keep Aramark Stock on Your Radar
The size of the U.S. hospitality industry as of the start of 2025 is estimated at more than $247 billion, and that figure is expected to surge to nearly $314 billion in the next five years
Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
In his latest report, Wedbush analyst Dan Ives revealed his top AI picks for 2025. Among them was the firm Pegasystems (NASDAQ: PEGA). The software company already had a great 2024, with shares
Xometry ernennt Sanjeev Singh Sahni zum Präsidenten, der an CEO Randy Altschuler berichtet
- Ehemaliger Vizepräsident des B2B-E-Commerce und Leiter des B2B- und B2C-Vertriebs von Wayfair wechselt zu Xometry, um globales Wachstum, Skalierung und betriebliche Effizienz weiter voranzutreiben
Moderna Shares Spike on H5N1 News—What’s Next for Investors?
Shares of Moderna Inc. (NASDAQ: MRNA) surged over 12% after news of the first confirmed death from the H5N1 bird flu in the United States. At one point, the stock had climbed over 14% before
Top 2 Auto Maintenance Stocks Gearing Up for 2025
A robust vehicle sales market bodes well for the auto maintenance market since consumers will need to service their cars to keep them operating efficiently. Even during contractions in the
Hindenburg Short Report Slams Carvana Over Alleged 'Grift'
Polarizing activist short-seller Hindenburg Research—known for its bombshell reports alleging corporate fraud and other malfeasance by companies including Nikola Corp. (NASDAQ: NKLA) and India's
Top Dividend Stocks to Buy Now as Bond Yields Could Lower
The concept of market relativity is more alive than ever in today’s economy, as gone are the days of individualistic price action in different asset classes and even stocks. With the advances in
3 Stocks Ringing in The New Year with Large Buyback Announcements
Share buybacks are an important way that corporate management teams look to return value to their shareholders. Buying back stock decreases the number of outstanding shares a company has in the
Woodward: Delivering Critical Components for the Aerospace Boom
Woodward Inc. (NASDAQ: WWD) manufactures critical control systems and components for the commercial aviation, industrial, and defense industries. Modern commercial passenger airliners can contain
Top 3 ETFs to Hedge Against Inflation in 2025
The Federal Open Market Committee closed 2024 with its third consecutive reduction to the overnight borrowing rate, while Chair Jerome Powell suggested the pace of rate cuts is likely to slow in
Rare Earth Revolution: Powering the Future of Technology
The global economy is undergoing a profound transformation that is being driven by the rapid advancement of technologies that promise to reshape industries and redefine the way we live. Electric
How AI Implementation Could Help MongoDB Roar Back in 2025
MongoDB (NASDAQ: MDB) had a rough year in 2024, with shares down an excruciating 40% as of the Dec. 26 close. However, Wall Street analysts appear to see light at the end of the tunnel for this tech



